Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer

Clinical trial NCT03937141 · TERMINATED

Trial details

NCT number: NCT03937141
Sponsor: Chinook Therapeutics, Inc. (formerly Aduro)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Head and Neck Cancer Recurrent Head and Neck Cancer

Start date: 2019-08-26
Primary completion: 2021-05-10
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.